Long Term Follow-Up After Patients Underwent Total Hip Replacement

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2013 by Hadassah Medical Organization.
Recruitment status was  Active, not recruiting
Information provided by (Responsible Party):
iri liebergall, Hadassah Medical Organization
ClinicalTrials.gov Identifier:
First received: August 23, 2012
Last updated: March 19, 2013
Last verified: March 2013
The investigators want to contact patients that underwent total hip replacement for the past ten years. The investigators will ask them about their daily living, functioning and quality of life.

Total Hip Replacement

Study Type: Observational
Study Design: Time Perspective: Prospective

Resource links provided by NLM:

Further study details as provided by Hadassah Medical Organization:

Primary Outcome Measures:
  • quality of life [ Time Frame: up to ten years ] [ Designated as safety issue: No ]
    quality of life will be assessed by the SF-12 questionnaire. We will compare between the results from the last visit to the current.

Secondary Outcome Measures:
  • functioning [ Time Frame: up to ten years ] [ Designated as safety issue: No ]
    functioning will be assessed by the Harris Hip Score. We will compare between the results from the last visit to the current visit

Estimated Enrollment: 150
Study Start Date: January 2013
Estimated Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)
total hip replacement, quality of life, functioning


Ages Eligible for Study:   28 Years to 85 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
men and women than underwent total hup replacment

Inclusion Criteria:

1. total hip replacement from 01.01.2002

Exclusion Criteria:

1. no

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01687322

Hadassah Medical Organization
Jerusalem, Israel
Sponsors and Collaborators
Hadassah Medical Organization
  More Information

Responsible Party: iri liebergall, Prof Meir (Iri) Liebergall, Chairman, Orthopedic Surgery Dept., Hadassah Medical Organization
ClinicalTrials.gov Identifier: NCT01687322     History of Changes
Other Study ID Numbers: lieb004-CTIL-HMO 
Study First Received: August 23, 2012
Last Updated: March 19, 2013
Health Authority: Israel: Ministry of Health

Keywords provided by Hadassah Medical Organization:
quality of life

ClinicalTrials.gov processed this record on May 02, 2016